Skip to main content
Livermore
Livermore
ZHEN

Inozyme Pharma, Inc.

INZYDelisted Jul 1, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001693011

Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Inozyme Pharma, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
80
+4 vs. Q3 2023
Shares held
50.1M
+2.62M (+5.5%) vs. Q3 2023
Total value
$213.3M
+$14.0M (+7.0%) vs. Q3 2023
New holders
13
42 more added
Sold out
9
15 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting INZY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 80 institutions
Q1 2021: 55 institutionsQ2 2021: 50 institutionsQ3 2021: 52 institutionsQ4 2021: 51 institutionsQ1 2022: 50 institutionsQ2 2022: 47 institutionsQ3 2022: 39 institutionsQ4 2022: 37 institutionsQ1 2023: 50 institutionsQ2 2023: 74 institutionsQ3 2023: 77 institutionsQ4 2023: 80 institutionsQ1 2024: 89 institutionsQ2 2024: 90 institutionsQ3 2024: 89 institutionsQ4 2024: 105 institutionsQ1 2025: 97 institutionsQ2 2025: 87 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2023: $213.3M
Q1 2021: $379.4MQ2 2021: $337.1MQ3 2021: $202.7MQ4 2021: $118.2MQ1 2022: $71.2MQ2 2022: $149.4MQ3 2022: $82.7MQ4 2022: $30.4MQ1 2023: $183.4MQ2 2023: $190.3MQ3 2023: $204.6MQ4 2023: $213.3MQ1 2024: $382.0MQ2 2024: $240.1MQ3 2024: $285.5MQ4 2024: $145.1MQ1 2025: $42.5MQ2 2025: $202.3MQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding INZY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 202587$202.3M
Q1 202597$42.5M
Q4 2024105$145.1M
Q3 202489$285.5M
Q2 202490$240.1M
Q1 202489$382.0M
Q4 202380$213.3M
Q3 202377$204.6M
Q2 202374$190.3M
Q1 202350$183.4M
Q4 202237$30.4M
Q3 202239$82.7M
Q2 202247$149.4M
Q1 202250$71.2M
Q4 202151$118.2M
Q3 202152$202.7M
Q2 202150$337.1M
Q1 202155$379.4M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Inozyme Pharma, Inc.; share changes are against Q3 2023.

Institutions holding INZY in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Advisor Group Holdings, Inc.50$2130.00%00.0%Unchanged
Metropolitan Life Insurance Co2,875$12.2K0.00%+1,006+53.8%Added
Amalgamated Bank2,952$13.0K0.00%−340−10.3%Reduced
Tower Research Capital LLC (TRC)3,892$16.6K0.00%−4,440−53.3%Reduced
Legal & General Group Plc4,033$17.2K0.00%+1,053+35.3%Added
Ameritas Investment Partners, Inc.4,805$20.5K0.00%+2,010+71.9%Added
Citigroup Inc6,741$28.7K0.00%+6,723+37,350.0%Added
California State Teachers Retirement System7,858$33.5K0.00%+389+5.2%Added
State Board of Administration of Florida Retirement System12,399$52.8K0.00%+12,399New
Price T Rowe Associates Inc12,696$55.0K0.00%+12,696New
New York State Common Retirement Fund13,301$56.7K0.00%−74−0.6%Reduced
Values First Advisors, Inc.13,898$59.2K0.04%+13,898New
Engineers Gate Manager LP14,519$61.9K0.00%+14,519New
Wells Fargo & Company14,694$62.6K0.00%+6,253+74.1%Added
Royal Bank of Canada15,102$64.0K0.00%+9,419+165.7%Added
Parallel Advisors, LLC16,033$68.3K0.00%+406+2.6%Added
Deutsche Bank AG16,234$69.2K0.00%00.0%Unchanged
Invesco Ltd.17,843$76.0K0.00%+4,795+36.7%Added
Alliancebernstein L.P.18,280$77.9K0.00%00.0%Unchanged
Voya Investment Management LLC20,080$85.5K0.00%+6,395+46.7%Added
SG Americas Securities, LLC21,236$90.0K0.00%+6,784+46.9%Added
Denali Advisors LLC22,000$93.7K0.03%−4,700−17.6%Reduced
Bank of Montreal21,900$99.2K0.00%+21,900New
American International Group, Inc.23,730$101.1K0.00%+6,838+40.5%Added
Manufacturers Life Insurance Company, The24,501$104.4K0.00%+9,949+68.4%Added
MetLife Investment Management26,507$112.9K0.00%+8,472+47.0%Added
Virtu Financial LLC26,678$114.0K0.01%+16,160+153.6%Added
American Century Companies Inc28,695$122.2K0.00%+10,622+58.8%Added
XTX Topco Ltd29,489$125.6K0.03%+29,489New
JPMorgan Chase & Co34,336$146.3K0.00%+12,336+56.1%Added
BIT Capital GmbH37,837$161.2K0.02%+8,708+29.9%Added
Alps Advisors Inc42,215$179.8K0.00%+42,215New
Susquehanna International Group, LLP43,657$186.0K0.00%+43,657New
AQR Capital Management LLC45,913$195.6K0.00%+26,169+132.5%Added
UBS Group AG46,207$196.8K0.00%+27,290+144.3%Added
Jane Street Group, LLC51,404$219.0K0.00%+51,404New
Bridgeway Capital Management, LLC51,800$220.7K0.00%−39,883−43.5%Reduced
Two Sigma Investments, LP53,700$228.8K0.00%−14,400−21.1%Reduced
Rhumbline Advisers60,294$256.8K0.00%+14,365+31.3%Added
Dimensional Fund Advisors LP63,685$271.8K0.00%+4,244+7.1%Added
Barclays PLC69,124$294.5K0.00%+59,904+649.7%Added
Two Sigma Advisers, LP70,700$301.2K0.00%−25,400−26.4%Reduced
Bank of America Corp73,698$314.0K0.00%−18,928−20.4%Reduced
Schonfeld Strategic Advisors LLC108,700$463.1K0.00%−203,180−65.1%Reduced
Morgan Stanley115,480$491.9K0.00%+89,108+337.9%Added
Charles Schwab Investment Management Inc121,650$518.2K0.00%+27,655+29.4%Added
Superstring Capital Management LP123,944$528.0K0.38%+123,944New
Bank of New York Mellon Corp158,015$673.1K0.00%+16,874+12.0%Added
Citadel Advisors LLC159,463$679.3K0.00%+25,453+19.0%Added
Nuveen Asset Management, LLC160,879$685.3K0.00%+23,130+16.8%Added
Gsa Capital Partners LLP167,004$711.0K0.06%+74,358+80.3%Added
Parkman Healthcare Partners LLC212,432$905.0K0.13%+36,536+20.8%Added
Renaissance Technologies LLC218,500$931.0K0.00%−77,108−26.1%Reduced
Overbrook Management Corp219,326$934.3K0.19%00.0%Unchanged
UBS Oconnor LLC244,928$1.04M0.03%+89,623+57.7%Added
Kennedy Capital Management, Inc.287,537$1.22M0.03%+287,537New
Woodline Partners LP300,000$1.28M0.01%+300,000New
MPM Oncology Impact Management LP323,813$1.38M0.32%−3,108−1.0%Reduced
Goldman Sachs Group Inc363,372$1.55M0.00%+309,484+574.3%Added
Octagon Capital Advisors LP400,000$1.70M0.27%−900,000−69.2%Reduced
Northern Trust Corp424,707$1.81M0.00%+90,060+26.9%Added
Laurion Capital Management LP557,329$2.37M0.09%−120,000−17.7%Reduced
Knott David M Jr564,549$2.40M0.92%+110,541+24.3%Added
State Street Corp746,533$3.18M0.00%+118,186+18.8%Added
Millennium Management LLC911,465$3.88M0.00%−415,406−31.3%Reduced
Geode Capital Management, LLC1,032,716$4.40M0.00%+209,893+25.5%Added
Blue Owl Capital Holdings LP1,270,027$5.41M1.29%+1,270,027New
Samsara BioCapital, LLC1,562,500$6.66M1.04%00.0%Unchanged
Sphera Funds Management Ltd.1,562,907$6.66M1.24%+328,000+26.6%Added
Affinity Asset Advisors, LLC1,885,802$8.03M1.60%+505,950+36.7%Added
FMR LLC2,272,306$9.68M0.00%−192,926−7.8%Reduced
Vanguard Group Inc2,385,022$10.2M0.00%+108,937+4.8%Added
NEA Management Company, LLC2,437,689$10.4M0.69%00.0%Unchanged
BlackRock Inc.3,042,330$13.0M0.00%+802,588+35.8%Added
Eventide Asset Management, LLC3,179,837$13.5M0.22%+54,837+1.8%Added
Samlyn Capital, LLC3,372,558$14.4M0.31%+127,350+3.9%Added
Rock Springs Capital Management LP3,681,174$15.7M0.39%00.0%Unchanged
Sofinnova Investments, Inc.4,280,308$18.2M1.02%00.0%Unchanged
Pivotal bioVenture Partners Investment Advisor LLC4,494,851$19.1M4.86%00.0%Unchanged
Adage Capital Partners GP, L.L.C.5,537,500$23.6M0.05%00.0%Unchanged
Point72 Asset Management, L.P.0$00.00%−700,000−100.0%Sold out
Marshall Wace, LLP0$00.00%−135,783−100.0%Sold out
Mirae Asset Global Investments Co., Ltd.0$00.00%−55,403−100.0%Sold out
Squarepoint Ops LLC0$00.00%−42,607−100.0%Sold out
Walleye Capital LLC0$00.00%−35,058−100.0%Sold out
STRS Ohio0$00.00%−9,900−100.0%Sold out
Group One Trading, L.P.0$00.00%−1,009−100.0%Sold out
Simplex Trading, LLC0$00.00%−1,001−100.0%Sold out
US Bancorp0$00.00%−129−100.0%Sold out
CHI Advisors LLC––––Not filed